Cargando…

Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis

BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) for which several new treatment options were recently introduced. Among them is the monoclonal anti-CD52 antibody alemtuzumab that depletes mainly B cells and T cells in the immune periphery. Cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simon, Micha, Ipek, Rojda, Homola, György A., Rovituso, Damiano M., Schampel, Andrea, Kleinschnitz, Christoph, Kuerten, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086993/ https://www.ncbi.nlm.nih.gov/pubmed/30098594 http://dx.doi.org/10.1186/s12974-018-1263-9

Ejemplares similares

CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
por: Rovituso, Damiano M., et al.
Publicado: (2016)

Contribution of LTi and T(H)17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis
por: Schropp, Verena, et al.
Publicado: (2019)

Danger: High Voltage—The Role of Voltage-Gated Calcium Channels in Central Nervous System Pathology
por: Schampel, Andrea, et al.
Publicado: (2017)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
por: Bail, Kathrin, et al.
Publicado: (2017)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients
por: Rovituso, Damiano M., et al.
Publicado: (2015)

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2021)

Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis
por: Alrashdi, Barakat, et al.
Publicado: (2019)

Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis
por: von Kutzleben, Stephanie, et al.
Publicado: (2017)

Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
por: Breakell, Thomas, et al.
Publicado: (2020)

Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood
por: Hohmann, Christopher, et al.
Publicado: (2014)

Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
por: DiSano, Krista D., et al.
Publicado: (2019)

The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis
por: Schropp, Verena, et al.
Publicado: (2023)

Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
por: Kapitza, Christopher, et al.
Publicado: (2021)

Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune Encephalomyelitis
por: Weier, Alicia, et al.
Publicado: (2022)

Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research
por: Rottlaender, Andrea, et al.
Publicado: (2015)

CD52-targeted depletion by Alemtuzumab ameliorates allergic airway hyperreactivity and lung inflammation
por: Shafiei-Jahani, Pedram, et al.
Publicado: (2021)

B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
por: Chunder, Rittika, et al.
Publicado: (2020)

Early microvascular dysfunction in cerebral small vessel disease is not detectable on 3.0 Tesla magnetic resonance imaging: a longitudinal study in spontaneously hypertensive stroke-prone rats
por: Mencl, Stine, et al.
Publicado: (2013)

The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
por: Joppe, Karina, et al.
Publicado: (2019)

Split-Belt Training but Not Cerebellar Anodal tDCS Improves Stability Control and Reduces Risk of Fall in Patients with Multiple Sclerosis
por: Nguemeni, Carine, et al.
Publicado: (2021)

CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity
por: Gupta, Sasha, et al.
Publicado: (2023)

Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
por: Enders, Michael, et al.
Publicado: (2020)

The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2023)

Multiple Sclerosis and the Blood-Central Nervous System Barrier
por: Palmer, Alan M.
Publicado: (2013)

Clinical pharmacology of alemtuzumab, an anti‐CD52 immunomodulator, in multiple sclerosis
por: Li, Z., et al.
Publicado: (2018)

Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
por: Kasarello, Kaja, et al.
Publicado: (2021)

Restorative therapy using microglial depletion and repopulation for central nervous system injuries and diseases
por: Shi, Weipeng, et al.
Publicado: (2022)

Infection of the Central Nervous System, Sepsis and Amyotrophic Lateral Sclerosis
por: Fang, Fang, et al.
Publicado: (2011)

Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2022)

Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
por: Kuerten, Stefanie, et al.
Publicado: (2018)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Glyphosate-based herbicide: a risk factor for demyelinating conditions of the peripheral nervous system?
por: Szepanowski, Fabian, et al.
Publicado: (2019)

Cross-talks between the kidneys and the central nervous system in multiple sclerosis
por: Rostami, Sahar, et al.
Publicado: (2018)

Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system
por: Dusart, I., et al.
Publicado: (1992)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies
por: Maggi, Pietro, et al.
Publicado: (2018)

Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination
por: Chunder, Rittika, et al.
Publicado: (2022)

Anti‐CD52 antibody treatment in murine experimental autoimmune encephalomyelitis induces dynamic and differential modulation of innate immune cells in peripheral immune and central nervous systems
por: Barbour, Mark, et al.
Publicado: (2021)

Acute Tryptophan Depletion Moja-De: A Method to Study Central Nervous Serotonin Function in Children and Adolescents
por: Stewart, Richard M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g3nnmdoqf63n22vmf6dvc3hp55